☰

Michael K. Altenburg, Ph.D. - Publications

Affiliations: 
2007 Pathology University of North Carolina, Chapel Hill, Chapel Hill, NC 
Area:
Physiology Biology
Tree Info Grants Similar researchers PubMed Report error

16 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Smithies O, Lawrence M, Testen A, Horne LP, Wilder J, Altenburg M, Bleasdale B, Maeda N, Koklic T. Stable oligomeric clusters of gold nanoparticles: preparation, size distribution, derivatization, and physical and biological properties. Langmuir : the Acs Journal of Surfaces and Colloids. 30: 13394-404. PMID 25317930 DOI: 10.1021/La5032637  0.451
2011 Johnson LA, Arbones-Mainar JM, Fox RG, Pendse AA, Altenburg MK, Kim HS, Maeda N. Apolipoprotein E4 exaggerates diabetic dyslipidemia and atherosclerosis in mice lacking the LDL receptor. Diabetes. 60: 2285-94. PMID 21810592 DOI: 10.2337/Db11-0466  0.745
2010 Arbones-Mainar JM, Johnson LA, Altenburg MK, Kim HS, Maeda N. Impaired adipogenic response to thiazolidinediones in mice expressing human apolipoproteinE4. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 24: 3809-18. PMID 20501792 DOI: 10.1096/Fj.10-159517  0.773
2009 Pendse AA, Arbones-Mainar JM, Johnson LA, Altenburg MK, Maeda N. Apolipoprotein E knock-out and knock-in mice: atherosclerosis, metabolic syndrome, and beyond. Journal of Lipid Research. 50: S178-82. PMID 19060252 DOI: 10.1194/Jlr.R800070-Jlr200  0.805
2008 Arbones-Mainar JM, Johnson LA, Altenburg MK, Maeda N. Differential modulation of diet-induced obesity and adipocyte functionality by human apolipoprotein E3 and E4 in mice. International Journal of Obesity (2005). 32: 1595-605. PMID 18725890 DOI: 10.1038/Ijo.2008.143  0.77
2008 Johnson LA, Altenburg MK, Walzem RL, Scanga LT, Maeda N. Absence of hyperlipidemia in LDL receptor-deficient mice having apolipoprotein B100 without the putative receptor-binding sequences. Arteriosclerosis, Thrombosis, and Vascular Biology. 28: 1745-52. PMID 18617647 DOI: 10.1161/Atvbaha.108.169680  0.765
2008 Altenburg M, Arbones-Mainar J, Johnson L, Wilder J, Maeda N. Human LDL receptor enhances sequestration of ApoE4 and VLDL remnants on the surface of hepatocytes but not their internalization in mice. Arteriosclerosis, Thrombosis, and Vascular Biology. 28: 1104-10. PMID 18369154 DOI: 10.1161/Atvbaha.108.164863  0.815
2007 Altenburg M, Homeister J, Doherty H, Maeda N. Genetics of atherosclerosis in murine models. Current Drug Targets. 8: 1161-71. PMID 18045094 DOI: 10.2174/138945007782403801  0.745
2007 Altenburg M, Johnson L, Wilder J, Maeda N. Apolipoprotein E4 in macrophages enhances atherogenesis in a low density lipoprotein receptor-dependent manner. The Journal of Biological Chemistry. 282: 7817-24. PMID 17234631 DOI: 10.1074/Jbc.M610712200  0.804
2007 Lucic D, Huang ZH, Gu de S, Altenburg MK, Maeda N, Mazzone T. Regulation of macrophage apoE secretion and sterol efflux by the LDL receptor. Journal of Lipid Research. 48: 366-72. PMID 17079794 DOI: 10.1194/Jlr.M600259-Jlr200  0.674
2004 Knouff C, Briand O, Lestavel S, Clavey V, Altenburg M, Maeda N. Defective VLDL metabolism and severe atherosclerosis in mice expressing human apolipoprotein E isoforms but lacking the LDL receptor. Biochimica Et Biophysica Acta. 1684: 8-17. PMID 15450205 DOI: 10.1016/J.Bbalip.2004.03.004  0.841
2004 Klett EL, Lu K, Kosters A, Vink E, Lee MH, Altenburg M, Shefer S, Batta AK, Yu H, Chen J, Klein R, Looije N, Oude-Elferink R, Groen AK, Maeda N, et al. A mouse model of sitosterolemia: absence of Abcg8/sterolin-2 results in failure to secrete biliary cholesterol. Bmc Medicine. 2: 5. PMID 15040800 DOI: 10.1186/1741-7015-2-5  0.538
2004 Malloy SI, Altenburg MK, Knouff C, Lanningham-Foster L, Parks JS, Maeda N. Harmful effects of increased LDLR expression in mice with human APOE*4 but not APOE*3. Arteriosclerosis, Thrombosis, and Vascular Biology. 24: 91-7. PMID 12969990 DOI: 10.1161/01.Atv.0000094963.07902.Fb  0.796
2004 Altenburg MK, Malloy SI, Knouff C, Parks JS, Maeda N. ApoE4 trapping by the low density lipoprotein receptor International Congress Series. 1262: 388-391. DOI: 10.1016/j.ics.2003.11.035  0.735
2001 Knouff C, Malloy S, Wilder J, Altenburg MK, Maeda N. Doubling expression of the low density lipoprotein receptor by truncation of the 3'-untranslated region sequence ameliorates type iii hyperlipoproteinemia in mice expressing the human apoe2 isoform. The Journal of Biological Chemistry. 276: 3856-62. PMID 11076954 DOI: 10.1074/Jbc.M009423200  0.783
1999 Knouff C, Hinsdale ME, Mezdour H, Altenburg MK, Watanabe M, Quarfordt SH, Sullivan PM, Maeda N. Apo E structure determines VLDL clearance and atherosclerosis risk in mice. The Journal of Clinical Investigation. 103: 1579-86. PMID 10359567 DOI: 10.1172/Jci6172  0.828
Show low-probability matches.